complianceresourcesllc.com

What It Is

Compliance Resources, LLC is a privately held, woman-owned small business based in North Carolina, USA, founded in 2000 and accredited by the Better Business Bureau. According to the site content, it primarily serves the pharmaceutical industry, offering consulting services such as regulatory submission preparation, document publishing, quality systems, and GxP audits. It is worth noting that the website does not present it as a standard SaaS or enterprise software platform; it is better understood as a professional compliance services firm.

Core Functions and Capabilities

Its services cover drug development and the FDA regulatory pathway, including regulatory strategy consulting, FDA meeting question design and briefing package preparation, pre-meeting rehearsals, and meeting support. It can write, compile, and submit applications such as IND, ANDA, and NDA, supports eCTD format, and provides writing services for CSRs, IBs, product labeling, orphan drug applications, annual reports, FDA responses, and more. It also offers document and data QA audits, FDA Electronic Submissions Gateway electronic submissions, annual establishment registration, clinicaltrials.gov registration, and U.S. agent services for foreign pharmaceutical companies.

Quality Systems and Compliance

On the compliance operations side, Compliance Resources can help define processes, write SOPs, develop form templates, conduct internal process audits, and support vendor management programs and GxP audits. Its audit scope includes cGMP, GLP, GCLP, and GCP, as well as mock FDA pre-approval inspections, deviation management, CAPA, and root cause analysis. These capabilities can be practically valuable for pharmaceutical companies preparing submissions and responding to inspections.

Pricing, Software Maturity, and Limitations

The site does not disclose any plans, pricing, payment methods, delivery timelines, online systems, cloud deployment, self-hosting options, team permissions, third-party integrations, APIs, or developer support information. As a result, its product maturity cannot be assessed from a SaaS perspective. If a company is looking to purchase a collaborative regulatory document management system or an electronic submission platform, these missing details should be key points to confirm during commercial discussions.

Who It Is For and Access from China

It is suitable for pharmaceutical companies pursuing U.S. FDA submissions and needing eCTD publishing, GxP audits, QMS development, or U.S. agent services, especially companies without an in-house regulatory affairs team. The source text does not state how accessible it is from China, and payment methods are also unknown. Domestic Chinese companies looking for localized alternatives may consider China-based CROs or regulatory consulting firms; if a software platform is required, options such as Veeva, MasterControl, Ennov, and Extedo may be worth comparing.